- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Exosens SAS (EXENS)
Exosens SAS stock price live, this page displays EPA EXENS stock exchange data. View the EXENS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Exosens SAS real time stock price chart below.
What Is the Exosens SAS Stock Price Today?
The Exosens SAS stock price today is 64.65.
What Is the Stock Symbol for Exosens SAS?
The stock symbol for Exosens SAS is "EXENS."
What Stock Exchange Does Exosens SAS Trade On?
Exosens SAS is listed and trades on the Paris stock exchange.
Is Exosens SAS a Good Stock to Buy?
Determining whether Exosens SAS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXENS quote. (ISIN: FR001400Q9V2)
What Is the Exosens SAS Stock Price Today?
The Exosens SAS stock price today is 64.65.
What Is the Stock Symbol for Exosens SAS?
The stock symbol for Exosens SAS is "EXENS."
What Stock Exchange Does Exosens SAS Trade On?
Exosens SAS is listed and trades on the Paris stock exchange.
Is Exosens SAS a Good Stock to Buy?
Determining whether Exosens SAS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXENS quote. (ISIN: FR001400Q9V2)
64.65
-0.45(-0.69%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
63.20
64.75
52 wk Range
32.70
74.00
Earnings results expected in 3 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
63.2064.75
52 wk Range
32.7074.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EXENS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
66.83
Upside
+3.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Mimbeau Holding receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mimbeau Holding receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mimbeau Holding receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Mimbeau Holding receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mimbeau Holding receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.
Exosens SAS Earnings Call Summary for Q2/2025
- Exosens reported 20% YoY revenue growth to €224.5M in H1 2025, with adjusted EBITDA up 24% to €69.5M
- Stock rose 2.7% post-earnings, trading near 52-week high of $60.48; company projects high teens revenue growth for 2025
- 5G night vision technology launch set for September; new US manufacturing facility planned to expand production capacity
- Strong performance driven by defense market expansion in NATO countries and focus on night vision and imaging technologies
- Company maintains positive outlook, targeting selective M&A and sustaining leverage ratio around 2x
Last Updated: 2025-10-14, 06:16 p/m
Read Full TranscriptCompare EXENS to Peers and Sector
Metrics to compare | EXENS | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipEXENSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 47.0x | 32.6x | 12.8x | |
PEG Ratio | 1.25 | 0.28 | 0.03 | |
Price/Book | 7.4x | 5.0x | 1.4x | |
Price / LTM Sales | 7.0x | 2.2x | 1.3x | |
Upside (Analyst Target) | 1.8% | 25.5% | 19.0% | |
Fair Value Upside | Unlock | −1.9% | 6.1% | Unlock |
Analyst Ratings
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 66.83
(+3.37% Upside)
Earnings
Latest Release
Feb 23, 2026
EPS / Forecast
-- / --
Revenue / Forecast
140.4M / 142.1M
People Also Watch
FAQ
What Is the Exosens (EXENS) Stock Price Today?
The Exosens stock price today is 64.65 EUR.
What Stock Exchange Does Exosens Trade On?
Exosens is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Exosens?
The stock symbol for Exosens is "EXENS."
Does Exosens Pay Dividends? What’s The Current Dividend Yield?
The Exosens dividend yield is 0.46%.
What Is the Exosens Market Cap?
As of today, Exosens market cap is 3.30B EUR.
What Is Exosens's Earnings Per Share (TTM)?
The Exosens EPS (TTM) is 1.38.
When Is the Next Exosens Earnings Date?
Exosens will release its next earnings report on Apr 27, 2026.
From a Technical Analysis Perspective, Is EXENS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Exosens Stock Split?
Exosens has split 0 times.
How Many Employees Does Exosens Have?
Exosens has 1499 employees.
What is the current trading status of Exosens (EXENS)?
As of Apr 24, 2026, Exosens (EXENS) is trading at a price of 64.65 EUR, with a previous close of 65.10 EUR. The stock has fluctuated within a day range of 63.20 EUR to 64.75 EUR, while its 52-week range spans from 32.70 EUR to 74.00 EUR.
What Is Exosens (EXENS) Price Target According to Analysts?
The average 12-month price target for Exosens is 66.83 EUR, with a high estimate of 75 EUR and a low estimate of 59.3 EUR. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +3.37% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.